Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:131
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size

Table of Contents   
Year : 2017  |  Volume : 10  |  Issue : 2  |  Page : 491-492
My experiences in hospital infection control: We have to learn hospital infection control at the first day of medical education for students, do you agree with me?

Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Click here for correspondence address and email

Date of Web Publication22-Jun-2017

How to cite this article:
Tavana AM. My experiences in hospital infection control: We have to learn hospital infection control at the first day of medical education for students, do you agree with me?. Ann Trop Med Public Health 2017;10:491-2

How to cite this URL:
Tavana AM. My experiences in hospital infection control: We have to learn hospital infection control at the first day of medical education for students, do you agree with me?. Ann Trop Med Public Health [serial online] 2017 [cited 2020 Feb 19];10:491-2. Available from:
There are many reports which showed that the number of hospital infections is increasing sharply in both developed and developing countries.[1],[2],[3] We are known that there are two type of hospital infection, either hospital acquired infection or community acquired infection. Nowadays, hospital infection is a major health problem even in developed countries.[4],[5],[6],[7] Many organisms are present in hospitals and their control is impossible because antibiotic resistance has increased in the last decade. Many new organisms are also involved in different infection, which are not introduced by the scientists at present. Health care workers (HCW) are also at risk. Few cases were appeared in HCW, and unfortunate with death results and incurable diseases.

What we have to do in order to reduce the risk are as follows:

  • Education, education and education but when that could be useful, I believe at the first day of MD training, do not be late that could cause many difficulties.
  • Take care, take care and take care from different health standards measures and wearing protective equipment for HCW in order to reduce the risk. Of course that must be checked at the first day of MD training.
  • Lesson from field of hospital those things which could not be forgotten by any M.D students.
  • Do all together not for yourself as HCW but also care for your patients and work together regularly in order to reduce the hospital infections risk as much as you can.
  • Exchange the experience of hospital infection committee with other same committee in other hospital reguarllay
  • Exchange the experience of hospital infection teams with other same other hospital regularly.
  • Do not use any more disinfectant or antiseptic in hospital, sometime clean the hospital and use detergent may be enough.
  • Keep dry hospital as much as you can because wet environment is the best environment for growth of many dangers organism like P. aueroginosa, Staphylococcus aureus, Kelebsilla spp.  Escherichia More Details coli, and Streptococcus pneumoniae According to Acquisition and Patient Characteristics.[8]
  • Do precaution as much as you can and take care yourself by considering safety regulations in high level and do not forget in unknown infection may be you as index cases or super spreader [9] and may be risk factor for different diseases is unknown.[10]
  • Any contaminated material must autoclaved before to throwaway in the environment.
  • It must not be forgotten that hand hygiene is very important, thus wash your hand regularly in particular when you are visiting the patients or touching any hospital environment and unstrielies material and equipment.
  • Write any accident when you are working in hospital and think how that could be prevented in the future.
  • Do not forget teach to the student anytime for this important matter and ask them to take care them- selves and remember the diseases comes day by days of course the type of diseases is not the same.[11],[12],[13],[14]
  • use any experiences like [15],[16],[17],[18] thus we have to learn at beginning of the course in M.D degree.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Ataee RA, Habibian S, Mehrabi-Tavana A, Ahmadi Z, Jonaidi N, Salesi M. et al. Determination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniae in Iran. Ann Clin Microbiol Antimicrob 2014;13:53-doi: 10.1186/s12941-014-0053-1  Back to cited text no. 1
van Cutsem G, Isaakidis P, Farley J, Nardell E, Volchenkov G, Cox H. et al. Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key. Clin Infect Dis 2016;62:Suppl 3S238-43.doi: 10.1093/cid/ciw012  Back to cited text no. 2
Kovacs CS, Fatica C, Butler R, Gordon SM, Fraser TG. Hospital-acquired Staphylococcus aureus primary bloodstream infection: A comparison of events that do and do not meet the central line-associated bloodstream infection definition. Am J Infect Control. 2016;5.pii: S0196-6553(16)30184-5. doi: 10.1016/j.ajic.2016.03.038.  Back to cited text no. 3
Mehrabi Tavana A, Ataee RA, Gerami ME, Gooya MM, Karami A, Ranjbar R. et al. BRIEF REPORT: A study investigating the Streptococcus pneumoniae pattern among Iranian patients. Arch Pharmacy Practice 2012;3:122-27.  Back to cited text no. 4
Ataee RA, Tavana AM, Hosseini SMJ, Moridi K, Zadegan MG. A method for antibiotic susceptibility testing: applicable and accurate. Jundishapur J Microbiol 2011;5:341-5.  Back to cited text no. 5
Ranjbar R, Afshar D, Mehrabi Tavana A, Najafi A, Pourali F, Safiri Z. et al. Development of multiplex PCR for simultaneous detection of three pathogenic Shigella species. Iran J Public Health 2014;43:1657-63.  Back to cited text no. 6
Mehrabi Tavana A, Ataee RA. invasive pneumococcal disease (ipd) serotype frequency in Iranian patients. Iran Red Crescent Med J 2013;15:740-2.doi:10.5812/ircmj.4145  Back to cited text no. 7
Gradel KO, Nielsen SL, Pedersen C, Knudsen JD, Østergaard C, Arpi M. Seasonal variation of Escherichia coli, Staphylococcus aureus, and Streptococcus pneumoniae bacteremia according to acquisition and patient characteristics: A population-based study. Infect Control Hosp Epidemiol. 2016;4:1-8.  Back to cited text no. 8
Mehrabi Tavana A, Chinikar S, Mazaheri V. The seroepidemiological aspects of Crimean-Congo hemorrhagic fever in three health workers: A report from Iran. Arch Iranian Med 2002;5:255-58.  Back to cited text no. 9
Ataee RA, Mehrabi-Tavana A, Izadi M, Hosseini SM, Ataee MH. Bacterial meningitis: A new risk factor. J Res Med Sci 2011;16:207-10.  Back to cited text no. 10
Tavana AM. Sandfly fever in the world. Ann Trop Med Public Health [serial online] 2015 8:83-7. Available from: [Last accessed on 2016 May 11].  Back to cited text no. 11
Tavana AM. Pandemic influenza A H1N1 in Iran and lessons learnt. Ann Trop Med Public Health 2012;5:295-7.  Back to cited text no. 12
  [Full text]  
Mehrabi Tavana A. Recent pandemic influenza and it's published articles distribution in the world. Iranian Journal of Nursing and Midwifery Research 2012;17:255.  Back to cited text no. 13
Tavana AM. Dental implantation and anaerobic bacteria. Indian J Dent Res 2012;23:554-doi: 10.4103/0970-9290.104972  Back to cited text no. 14
Tavana AM. Natural honey helps as diet-mediated for tuberculosis prevention or treatment. Ann Trop Med Public Health 2011;4:145-6.  Back to cited text no. 15
  [Full text]  
Tavana MA. Helicobacter pylori infection and its possible controlling public health measures at the present times. Ann Trop Med Public Health 2009;2:32.  Back to cited text no. 16
  [Full text]  
Tavana AM, Fallah Z, Zahraee SM, Asl HM, Rahbar M, Mafi M. et al. Effects of climate on the cholera outbreak in Iran during seven years (2000-2006). Ann Trop Med Public Health 2008;1:43-6.  Back to cited text no. 17
  [Full text]  
Tavana AM, Drucker DB, Hull PS, Boote V. Phospholipid molecular species distribution of oral Prevotella corporis clinical isolates. FEMS Immunol Med Microbiol. 1998;21:57-64.  Back to cited text no. 18

Correspondence Address:
Ali Mehrabi Tavana
Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1755-6783.196597

Rights and Permissions


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


 Article Access Statistics
    PDF Downloaded25    
    Comments [Add]    

Recommend this journal